Literature DB >> 11420199

Hyperhomocysteinaemia and MTHFR C677T gene polymorphism in renal transplant recipients.

A J Szabó1, T Tulassay, B Melegh, T Szabó, A Szabó, A Fekete, Z Süveges, G S Reusz.   

Abstract

AIM: To study the effect of folate treatment on hyperhomocysteinaemia and the effect of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism on total homocysteine and folate concentrations after renal transplantation.
METHODS: A total of 30 transplanted children and adolescents were investigated for total homocysteine and folate serum concentrations before and after folate treatment, as well as for the presence of the MTHFR C677T polymorphism.
RESULTS: The allele frequency of C677T polymorphism in the MTHFR gene in the study population (0.33) was not different to that in controls (0.38). Before folate treatment the homocysteine concentration was raised in all groups; following folate supplementation it was significantly decreased in the CC and CT groups, but not in the TT group. In patients with CC genotype, serum homocysteine correlated with serum creatinine and cholesterol, and time since transplantation before treatment.
CONCLUSION: Folate supplementation appears to be an effective strategy to normalise total homocysteine concentration in renal transplanted children and adolescents.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420199      PMCID: PMC1718862          DOI: 10.1136/adc.85.1.47

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  Concentrations of total homocysteine in plasma in chronic renal failure.

Authors:  C Soria; B Chadefaux; M Coudé; O Gaillard; P Kamoun
Journal:  Clin Chem       Date:  1990-12       Impact factor: 8.327

2.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.

Authors:  M J Stampfer; M R Malinow; W C Willett; L M Newcomer; B Upson; D Ullmann; P V Tishler; C H Hennekens
Journal:  JAMA       Date:  1992-08-19       Impact factor: 56.272

3.  Treatment of hyperhomocysteinemia in children on dialysis by folic acid.

Authors:  C H Schröder; A W de Boer; A M Giesen; L A Monnens; H Blom
Journal:  Pediatr Nephrol       Date:  1999-09       Impact factor: 3.714

4.  Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.

Authors:  M Födinger; C Mannhalter; G Wölfl; I Pabinger; E Müller; R Schmid; W H Hörl; G Sunder-Plassmann
Journal:  Kidney Int       Date:  1997-08       Impact factor: 10.612

5.  Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.

Authors:  M Födinger; G Wölfl; G Fischer; S Rasoul-Rockenschaub; R Schmid; W H Hörl; G Sunder-Plassmann
Journal:  Kidney Int       Date:  1999-03       Impact factor: 10.612

6.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.

Authors:  P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

7.  Methylenetetrahydrofolate-reductase gene C677T variant and kidney-transplant survival.

Authors:  O Liangos; R Kreutz; J Beige; G Offermann; A Distler; A M Sharma
Journal:  Nephrol Dial Transplant       Date:  1998-09       Impact factor: 5.992

8.  Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients.

Authors:  M Arnadottir; B Hultberg; V Vladov; P Nilsson-Ehle; H Thysell
Journal:  Transplantation       Date:  1996-02-15       Impact factor: 4.939

  8 in total
  3 in total

1.  Autonomic dysfunction in uremia assessed by heart rate variability.

Authors:  Kálmán Tory; Zsuzsanna Süveges; Erzsébet Horváth; Eva Bokor; Péter Sallay; Klára Berta; Attila Szabó; Tivadar Tulassay; György S Reusz
Journal:  Pediatr Nephrol       Date:  2003-09-17       Impact factor: 3.714

2.  Oxidative and Nitrosative Stress in Stable Renal Transplant Recipients with Respect to the Immunosuppression Protocol - Differences or Similarities?

Authors:  Tatjana Cvetković; Radmila Veličković-Radovanović; Dijana Stojanović; Nikola Stefanović; Aleksandra Ignjatović; Ivana Stojanović; Nikola Sladojević; Dušica Pavlović
Journal:  J Med Biochem       Date:  2015-07-14       Impact factor: 3.402

3.  Decisive evidence corroborates a null relationship between MTHFR C677T and chronic kidney disease: A case-control study and a meta-analysis.

Authors:  Hsueh-Lu Chang; Guei-Rung Chen; Po-Jen Hsiao; Chih-Chien Chiu; Ming-Cheng Tai; Chung-Cheng Kao; Dung-Jang Tsai; Hao Su; Yu-Hsuan Chen; Wei-Teing Chen; Sui-Lung Su
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.